Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1048291
                    [Title] => NAFLD is lion’s share of liver diseases
                    [Summary] => 
Nonalcoholic fatty liver disease may soon become the most important cause of chronic liver disease in the United States, “with a substantial clinical and economic impact.”

                    [DatePublished] => 2013-08-04 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

INOVA FAIRFAX

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1048291
                    [Title] => NAFLD is lion’s share of liver diseases
                    [Summary] => 
Nonalcoholic fatty liver disease may soon become the most important cause of chronic liver disease in the United States, “with a substantial clinical and economic impact.”

                    [DatePublished] => 2013-08-04 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

NAFLD is lion’s share of liver diseases

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | August 4, 2013 - 12:00am

Nonalcoholic fatty liver disease may soon become the most important cause of chronic liver disease in the United States, “with a substantial clinical and economic impact.”

Opinion